Mesoblast (MESO) Gains from Investment Securities: 2015-2022
Historic Gains from Investment Securities for Mesoblast (MESO) over the last 7 years, with Jun 2022 value amounting to -$24,000.
- Mesoblast's Gains from Investment Securities was N/A to -$4,000 in Q1 2023 from the same period last year, while for Mar 2023 it was -$32,000, marking a year-over-year change of. This contributed to the annual value of -$24,000 for FY2022, which is 31.43% up from last year.
- Per Mesoblast's latest filing, its Gains from Investment Securities stood at -$24,000 for FY2022, which was up 31.43% from -$35,000 recorded in FY2021.
- Mesoblast's Gains from Investment Securities' 5-year high stood at -$3,000 during FY2019, with a 5-year trough of -$35,000 in FY2021.
- Its 3-year average for Gains from Investment Securities is -$22,000, with a median of -$24,000 in 2022.
- As far as peak fluctuations go, Mesoblast's Gains from Investment Securities slumped by 2,400.00% in 2018, and later surged by 88.00% in 2019.
- Yearly analysis of 5 years shows Mesoblast's Gains from Investment Securities stood at -$25,000 in 2018, then skyrocketed by 88.00% to -$3,000 in 2019, then plummeted by 133.33% to -$7,000 in 2020, then slumped by 400.00% to -$35,000 in 2021, then soared by 31.43% to -$24,000 in 2022.